Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.040
-0.070 (-3.32%)
May 18, 2026, 4:10 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 2.64 billion as of May 18, 2026. Its market cap has increased by 19.29% in one year.
Market Cap
2.64B
Enterprise Value
2.65B
Revenue
98.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.04
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.64B, an increase of 3,352.59%. That is a compound annual growth rate of 17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.73B | -21.64% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 47.20B |
| Telix Pharmaceuticals | 5.04B |
| Neuren Pharmaceuticals | 1.63B |
| PYC Therapeutics | 1.41B |
| Clarity Pharmaceuticals | 1.08B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 481.08M |
| Racura Oncology | 475.23M |